根治性前列腺切除术后伴前列腺外侵犯的Grade Group 1前列腺癌患者生化复发风险
该研究回顾性分析2005至2022年间接受根治性前列腺切除术的6309例患者,其中GG1组2740例中169例(6.2%)存在EPE,GG2组3569例中1013例(28.4%)存在EPE,中位随访4年。GG1患者中EPE与无BCR生存无统计学显著差异(亚分布HR=0.88;95%CI:0.37-2.09),而GG2患者中EPE与更差的无BCR生存显著相关(亚分布HR=1.97,95%CI:1.54-2.52)。
要点
- GG1前列腺癌伴EPE者与不伴EPE者生化复发风险无统计学显著差异。
- GG2前列腺癌伴EPE者生化复发风险显著高于不伴EPE者(亚分布HR=1.97)。
- GG1患者EPE发生率为6.2%,GG2患者为28.4%。
核心结论
- 部分GG1前列腺癌可突破前列腺包膜,但伴EPE的GG1患者生化复发及生存结局与不伴EPE的GG1患者相似。
- 在GG2患者中,EPE提示预后更差。
研究设计与样本
- 回顾性分析本机构2005至2022年间接受根治性前列腺切除术的前列腺癌患者数据库,纳入最终病理为GG1和GG2的患者。
- 采用Fine-Gray竞争风险模型,包含EPE(有vs无)与GG(GG1 vs GG2)的交互项,分析疾病组与无BCR生存的关系。
- 队列共6309例男性,GG1组2740例中169例(6.2%)有EPE,GG2组3569例中1013例(28.4%)有EPE,中位随访4年。
主要发现
- 6309例患者中400例(6.3%)发生BCR。
- GG1患者中有EPE vs 无EPE的无BCR生存无统计学显著差异(亚分布HR=0.88;95%CI:0.37-2.09)。
- GG2患者中有EPE vs 无EPE的无BCR生存显著更差(亚分布HR=1.97,95%CI:1.54-2.52)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to examine the association of extraprostatic extension (EPE) with biochemical recurrence (BCR) separately in men with Grade Group (GG) 1 and GG2 prostate cancer (PCa) treated with radical prostatectomy. MATERIALS AND METHODS: We reviewed our institutional database of patients who underwent radical prostatectomy for PCa between 2005 and 2022 and identified patients with GG1 and GG2 disease on final pathology. Fine-Gray competing risk models with an interaction between EPE (yes vs no) and GG (GG1 vs GG2) were used to examine the relationship between disease group and BCR-free survival. RESULTS: The cohort consisted of 6309 men, of whom 169/2740 (6.2%) with GG1 disease had EPE while 1013/3569 (28.4%) with GG2 disease had EPE. Median follow-up was 4 years. BCR occurred in 400/6309 (6.3%) patients. For men with GG1, there was no statistically significant difference in BCR-free survival for men with vs without EPE (subdistribution HR = 0.88; 95% CI: 0.37-2.09). However, for GG2 patients BCR-free survival was significantly worse for those with vs without EPE (subdistribution HR = 1.97, 95% CI: 1.54-2.52). CONCLUSIONS: Although there is a subset of GG1 PCas capable of invading through the prostatic capsule, patients with GG1 PCa and EPE at prostatectomy experience similar biochemical recurrence and survival outcomes compared to GG1 patients without EPE. However, among men with GG2, EPE connotes a worse prognosis.
引用
- Rezaee ME, Pallauf M, Fletcher SA, et al. Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy. J Urol. 2023. PMID: 38109699. doi:10.1097/JU.0000000000003825
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。